- Home
- SLGL vs CPIX Comparison
SLGL vs CPIX Comparison
Compare SLGL & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- CPIX
- Stock Information
- Founded
- SLGL 1997
- CPIX 1999
- Country
- SLGL Israel
- CPIX United States
- Employees
- SLGL N/A
- CPIX N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- SLGL Health Care
- CPIX Health Care
- Exchange
- SLGL Nasdaq
- CPIX Nasdaq
- Market Cap
- SLGL 49.4M
- CPIX 48.5M
- IPO Year
- SLGL 2018
- CPIX 2009
- Fundamental
- Price
- SLGL $23.48
- CPIX $3.40
- Analyst Decision
- SLGL Buy
- CPIX
- Analyst Count
- SLGL 1
- CPIX 0
- Target Price
- SLGL $40.00
- CPIX N/A
- AVG Volume (30 Days)
- SLGL 30.1K
- CPIX 67.7K
- Earning Date
- SLGL 08-15-2025
- CPIX 08-05-2025
- Dividend Yield
- SLGL N/A
- CPIX N/A
- EPS Growth
- SLGL N/A
- CPIX N/A
- EPS
- SLGL N/A
- CPIX N/A
- Revenue
- SLGL $23,931,000.00
- CPIX $42,071,813.00
- Revenue This Year
- SLGL N/A
- CPIX N/A
- Revenue Next Year
- SLGL $31.17
- CPIX N/A
- P/E Ratio
- SLGL N/A
- CPIX N/A
- Revenue Growth
- SLGL 264.86
- CPIX 11.34
- 52 Week Low
- SLGL $4.01
- CPIX $1.04
- 52 Week High
- SLGL $26.89
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- SLGL 72.14
- CPIX 51.98
- Support Level
- SLGL $20.06
- CPIX $3.23
- Resistance Level
- SLGL $26.89
- CPIX $3.38
- Average True Range (ATR)
- SLGL 2.57
- CPIX 0.24
- MACD
- SLGL 0.63
- CPIX 0.05
- Stochastic Oscillator
- SLGL 75.10
- CPIX 89.53
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.